Companies: 10,795·Total market cap: $144.5T
Ascentage Pharma Group International

Ascentage Pharma Group International

AAPGVOTCHealthcare
$17.38
+$0.13(+0.75%)
Market Cap$127308500
P/E Ratio—
52W High$18.0
52W Low$16.5
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Ascentage Pharma Group International（AAPGV）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AAPGV · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.32aapgv eps ttm · aapgv earnings per shareEarnings history
PE Ratio (TTM)—aapgv pe ratio ttm · aapgv price to earningsPE Ratio deep dive
Revenue (TTM)$83.3Maapgv revenue ttm · aapgv annual revenueFull revenue history
Dividend Yield不分红does aapgv pay dividends · aapgv dividend yieldDividend history
Shares Outstanding75.5Maapgv shares outstanding · aapgv floatShares outstanding history
Next EarningsTBAaapgv earnings date · aapgv next earningsEarnings history

探索 Ascentage Pharma Group International 数据

aapgv stock data · financials
市值$127.3Maapgv market cap · aapgv valuation
分析师预测—
股息不分红does ascentage pharma group international pay dividends · aapgv dividend yield
营收$980.6M+341.77%ascentage pharma group international annual revenue · aapgv revenue
盈利EPS $-1.34+89.79%aapgv earnings · aapgv eps
市盈率—aapgv pe ratio · aapgv price to earnings

财务快照

完整财报
FY 2024Revenue$980.6M▲ +341.77% YoY
202220232024
ascentage pharma group international revenue · aapgv revenue 2024
FY 2024Net Income-$405.4M▲ +56.20% YoY
202220232024
ascentage pharma group international net income · aapgv profit 2024
FY 2024EPS$-1.34▲ +89.79% YoY
202220232024
aapgv eps · ascentage pharma group international earnings per share 2024
TTM:Revenue: $83.3MNet Income: -$94.0MEPS: $-0.32View income statement →

股票表现

完整历史
1D+0.00%
1W-6.31%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+0.00%

关于 Ascentage Pharma Group International

CEODajun Yang
IPO DateJan 24, 2025
Employees574
CountryCN
Websiteascentage.cn

Ascentage Pharma Group International a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's…

BiotechnologyHealthcareOTCCN

what is ascentage pharma group international · aapgv stock overview · ascentage pharma group international company profile · who is ascentage pharma group international ceo · aapgv OTC · ascentage pharma group international headquarters · ascentage pharma group international business segments

关于股票概览与关键数据

Ascentage Pharma Group International（AAPGV）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 24, 2025 在 OTC 上市。截至最近交易日，AAPGV 股价为 $17.38，市值约为 $127.3M。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2024 财年 Ascentage Pharma Group International 营收 $980.6M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Ascentage Pharma Group International（AAPGV）股价为 $17.38，在 OTC 上市，52周区间为 $16.50 – $18.00。

AAPGV 最新股价AAPGV quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议